Ipswich Investment Management Co. Inc. Acquires Shares of 1,800 Xylem Inc. (NYSE:XYL)

Ipswich Investment Management Co. Inc. acquired a new stake in Xylem Inc. (NYSE:XYL) in the 4th quarter, Holdings Channel reports. The fund acquired 1,800 shares of the industrial products company’s stock, valued at approximately $206,000.

Several other large investors also recently bought and sold shares of XYL. Bruce G. Allen Investments LLC acquired a new position in Xylem in the fourth quarter valued at $27,000. NBC Securities Inc. purchased a new stake in shares of Xylem in the third quarter valued at about $38,000. KB Financial Partners LLC purchased a new stake in shares of Xylem in the first quarter valued at about $42,000. Coppell Advisory Solutions LLC purchased a new stake in shares of Xylem in the second quarter valued at about $45,000. Finally, Orion Capital Management LLC purchased a new stake in shares of Xylem in the third quarter valued at about $48,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Insider Activity

In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $122.89, for a total value of $122,890.00. Following the sale, the chief accounting officer now directly owns 2,935 shares in the company, valued at $360,682.15. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, SVP Franz Cerwinka sold 2,408 shares of the firm’s stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total transaction of $293,270.32. Following the sale, the senior vice president now owns 11,750 shares in the company, valued at $1,431,032.50. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CAO Geri-Michelle Mcshane sold 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total transaction of $122,890.00. Following the sale, the chief accounting officer now owns 2,935 shares in the company, valued at approximately $360,682.15. The disclosure for this sale can be found here. Company insiders own 0.27% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently commented on XYL. Citigroup upped their target price on shares of Xylem from $126.00 to $139.00 and gave the company a “neutral” rating in a report on Monday, April 8th. Raymond James raised shares of Xylem from an “underperform” rating to a “market perform” rating in a report on Thursday, January 4th. Oppenheimer upped their target price on shares of Xylem from $133.00 to $142.00 and gave the company an “outperform” rating in a report on Thursday. Stifel Nicolaus increased their price target on shares of Xylem from $136.00 to $150.00 and gave the stock a “buy” rating in a report on Wednesday, February 7th. Finally, BNP Paribas started coverage on shares of Xylem in a report on Tuesday, March 12th. They set an “outperform” rating and a $150.00 price target for the company. Four investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $138.11.

Xylem Price Performance

XYL traded up $0.68 on Friday, hitting $127.84. 2,250,015 shares of the company were exchanged, compared to its average volume of 921,680. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.30 and a current ratio of 1.76. The business’s fifty day moving average is $127.01 and its 200 day moving average is $112.36. Xylem Inc. has a fifty-two week low of $87.59 and a fifty-two week high of $130.86. The firm has a market capitalization of $30.99 billion, a P/E ratio of 47.00, a price-to-earnings-growth ratio of 2.53 and a beta of 1.10.

Xylem (NYSE:XYL) last issued its earnings results on Tuesday, February 6th. The industrial products company reported $0.99 earnings per share for the quarter, topping the consensus estimate of $0.96 by $0.03. Xylem had a net margin of 8.27% and a return on equity of 9.65%. The company had revenue of $2.12 billion for the quarter, compared to analyst estimates of $2.05 billion. During the same period in the prior year, the business posted $0.92 earnings per share. The firm’s revenue for the quarter was up 40.6% compared to the same quarter last year. As a group, sell-side analysts anticipate that Xylem Inc. will post 4.13 EPS for the current year.

Xylem Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 20th. Stockholders of record on Wednesday, February 21st were given a $0.36 dividend. The ex-dividend date was Tuesday, February 20th. This is a positive change from Xylem’s previous quarterly dividend of $0.33. This represents a $1.44 annualized dividend and a dividend yield of 1.13%. Xylem’s dividend payout ratio is currently 52.94%.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.